Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Hikma Pharmaceuticals Plc (HKMPF) Weighted-Average Shares Outstanding (Diluted) data is not available.
Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
Weighted-Average Shares Outstanding (Diluted) |
-- |
-- |
|
-- |
|
Balance Sheet Financials | |
$2.26B |
|
$2.33B |
|
$3.87B |
|
$5.13B |
|
$1.98B |
|
$653.00M |
|
$834.00M |
|
$2.81B |
|
$2.32B |
|
$1.17B |
|
$2.32B |
|
-- |
|
Cash Flow Statement Financials | |
$564.00M |
|
$-381.00M |
|
$-188.00M |
|
$205.00M |
|
$188.00M |
|
$-17.00M |
|
-- |
|
-- |
|
-- |
|
Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |